Glenn Pierce

Insider Reports History

Entity
Individual
Signature
/s/ Scott MacDonald, as Attorney-in-Fact for Glenn Pierce
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Glenn Pierce:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Voyager Therapeutics, Inc. Director Stock Option (Right to Buy) 24K Jun 5, 2024 Direct
Global Blood Therapeutics, Inc. Director Common Stock 0 $46.99 Oct 5, 2022 Direct
Global Blood Therapeutics, Inc. Director Restricted Stock Units 0 Oct 5, 2022 Direct
Global Blood Therapeutics, Inc. Director Stock Option (Right to Buy) 0 Oct 5, 2022 Direct

Insider Reports Filed by Glenn Pierce

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VYGR Voyager Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
VYGR Voyager Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 7, 2023 Director
GBT Global Blood Therapeutics, Inc. Oct 5, 2022 10 $0 4 Oct 6, 2022 Director
VYGR Voyager Therapeutics, Inc. Jul 14, 2022 1 -$63.7K 4 Jul 18, 2022 Director
GBT Global Blood Therapeutics, Inc. Jun 14, 2022 4 $0 4 Jun 16, 2022 Director
VYGR Voyager Therapeutics, Inc. Jun 6, 2022 1 $0 4 Jun 8, 2022 Director
VYGR Voyager Therapeutics, Inc. Jan 13, 2022 2 $0 4 Jan 18, 2022 Interim CSO, Director
GBT Global Blood Therapeutics, Inc. Jun 17, 2021 4 $0 4 Jun 21, 2021 Director
VYGR Voyager Therapeutics, Inc. Jun 7, 2021 1 $0 4 Jun 8, 2021 Interim CSO, Director
VYGR Voyager Therapeutics, Inc. Jun 3, 2021 1 $0 4 Jun 4, 2021 Interim CSO, Director